Here are four notes:
1. Implanet upgraded from the Pink market.
2. The company began trading on OTCQX on April 13. It used its existing stock symbol, “IMPZY.”
3. BNY Mellon is Implanet’s Principal American Liaison on OTCQX.
4. Implanet develops vertebral and knee surgery devices.
“Trading on OTCQX will allow Implanet to expand its shareholder base and visibility in the U.S. market without incurring the high costs and duplicative regulatory requirements of a U.S. stock exchange listing,” said Jason Paltrowitz, executive vice president of corporate services, OTC Markets Group.
More articles on devices:
Rush Health partners with United Airlines to provide orthopedic, spine procedures: 4 observations
Expanding Orthopedics appoints Dale Binke as VP: 3 things to know
EOS imaging’s spineEOS receives FDA approval: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
